BO
SRPT icon

BRR OpCo’s Sarepta Therapeutics SRPT Stock Holding History

BRR OpCo’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$418K Sell
3,780
-43
-1% -$4.33K 0.05% 143
2022
Q2 		$287K Sell
3,823
-5,688
-60% -$418K 0.03% 159
2022
Q1 		$743K Buy
9,511
+5,731
+152% +$439K 0.08% 120
2021
Q4 		$340K Sell
3,780
-6,241
-62% -$534K 0.04% 164
2021
Q3 		$927K Buy
10,021
+5,528
+123% +$426K 0.11% 102
2021
Q2 		$349K Sell
4,493
-106
-2% -$8.04K 0.04% 167
2021
Q1 		$343K Sell
4,599
-9,287
-67% -$857K 0.04% 157
2020
Q4 		$2.37M Buy
13,886
+2,447
+21% +$363K 0.35% 34
2020
Q3 		$1.61M Sell
11,439
-1,663
-13% -$253K 0.27% 37
2020
Q2 		$2.1M Buy
13,102
+4,779
+57% +$650K 0.36% 29
2020
Q1 		$814K Buy
8,323
+1,683
+25% +$192K 0.16% 75
2019
Q4 		$857K Buy
6,640
+3,322
+100% +$335K 0.12% 90
2019
Q3 		$250K Sell
3,318
-4,082
-55% -$482K 0.04% 155
2019
Q2 		$1.12M Buy
7,400
+4,558
+160% +$554K 0.18% 48
2019
Q1 		$339K Buy
+2,842
New +$365K 0.06% 119

Other funds holding SRPT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BRR OpCo's SRPT Position: Q3 2022 in Review

BRR OpCo reduced its Sarepta Therapeutics (SRPT) stake by 1.1% in Q3 2022, selling an estimated $4.33K and leaving 3,780 shares worth $418K. The position accounts for 0.05% of the portfolio, ranked #143.

BRR OpCo first reported a position in SRPT in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.37M in Q4 2020. 375 funds tracked by Wall St. Rank hold SRPT as of Q3 2022.

  • BRR OpCo held 3,780 shares of Sarepta Therapeutics worth $418K as of Q3 2022.
  • BRR OpCo sold 43 Sarepta Therapeutics shares in Q3 2022, an estimated $4.33K.
  • Sarepta Therapeutics made up 0.05% of BRR OpCo's portfolio in Q3 2022, its #143 holding.
  • BRR OpCo first reported a position in Sarepta Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • BRR OpCo's Sarepta Therapeutics position peaked at $2.37M in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2022.

Based on BRR OpCo's 13F filing for Q3 2022, filed 8 Nov 2022.